ES8607270A1 - Furanonas - Google Patents

Furanonas

Info

Publication number: ES8607270A1
Authority: ES; Spain
Prior art keywords: increase; furanones; condensed; preparation; pharmaceutical use
Prior art date: 1984-05-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES542564A

Other languages

English (en)

Spanish (es)

Other versions

ES542564A0 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer AG

Original Assignee

Bayer AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-05-03

Filing date

1985-04-25

Publication date

1986-05-16

1985-04-25 Application filed by Bayer AG filed Critical Bayer AG

1986-05-16 Publication of ES8607270A1 publication Critical patent/ES8607270A1/es

1986-05-16 Publication of ES542564A0 publication Critical patent/ES542564A0/es

Status Expired legal-status Critical Current

Links

150000002241 furanones Chemical class 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
125000002252 acyl group Chemical group 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
230000036772 blood pressure Effects 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical compound O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 1
210000004400 mucous membrane Anatomy 0.000 abstract 1
230000002107 myocardial effect Effects 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
230000008961 swelling Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Cardiology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Seasonings (AREA)
Furan Compounds (AREA)
Saccharide Compounds (AREA)

ES542564A 1984-05-03 1985-04-25 Furanonas Expired ES8607270A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19843416293 DE3416293A1 (de)	1984-05-03	1984-05-03	Annellierte furanone, verfahren zu ihrer herstellun g und ihre verwendung in arzneimitteln

Publications (2)

Publication Number	Publication Date
ES8607270A1 true ES8607270A1 (es)	1986-05-16
ES542564A0 ES542564A0 (es)	1986-05-16

Family

ID=6234834

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
ES542564A Expired ES8607270A1 (es)	1984-05-03	1985-04-25	Furanonas
ES551451A Expired ES8701746A1 (es)	1984-05-03	1986-01-30	Procedimiento para la obtencion de furanonas.
ES551452A Expired ES8702396A1 (es)	1984-05-03	1986-01-30	Procedimiento para la obtencion de furanonas.

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
ES551451A Expired ES8701746A1 (es)	1984-05-03	1986-01-30	Procedimiento para la obtencion de furanonas.
ES551452A Expired ES8702396A1 (es)	1984-05-03	1986-01-30	Procedimiento para la obtencion de furanonas.

Country Status (9)

Country	Link
US (2)	US4668691A (fr)
EP (1)	EP0160256B1 (fr)
JP (1)	JPH0647584B2 (fr)
KR (1)	KR850008673A (fr)
AT (1)	ATE37545T1 (fr)
CA (1)	CA1259073A (fr)
DE (2)	DE3416293A1 (fr)
ES (3)	ES8607270A1 (fr)
HU (1)	HU194202B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1296010C (fr) *	1985-12-16	1992-02-18	Patrick F. King	Precurseurs de colorants a base de di- et de triarylurethane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3702853A (en) *	1970-01-13	1972-11-14	Syntex Corp	Certain 5-substituted tetrahydroiso-benzofuran-1-ones
US4491667A (en) *	1981-06-17	1985-01-01	Hitachi Chemical Company, Ltd.	Hexahydrophthalides

1984
- 1984-05-03 DE DE19843416293 patent/DE3416293A1/de not_active Withdrawn
1985
- 1985-04-18 US US06/724,374 patent/US4668691A/en not_active Expired - Lifetime
- 1985-04-20 DE DE8585104820T patent/DE3565263D1/de not_active Expired
- 1985-04-20 EP EP85104820A patent/EP0160256B1/fr not_active Expired
- 1985-04-20 AT AT85104820T patent/ATE37545T1/de not_active IP Right Cessation
- 1985-04-25 ES ES542564A patent/ES8607270A1/es not_active Expired
- 1985-04-30 JP JP60091289A patent/JPH0647584B2/ja not_active Expired - Lifetime
- 1985-05-01 KR KR1019850002952A patent/KR850008673A/ko not_active Ceased
- 1985-05-01 CA CA000480509A patent/CA1259073A/fr not_active Expired
- 1985-05-02 HU HU851683A patent/HU194202B/hu not_active IP Right Cessation
1986
- 1986-01-30 ES ES551451A patent/ES8701746A1/es not_active Expired
- 1986-01-30 ES ES551452A patent/ES8702396A1/es not_active Expired
- 1986-10-10 US US06/917,875 patent/US4762853A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPH0647584B2 (ja)	1994-06-22
JPS60239479A (ja)	1985-11-28
HU194202B (en)	1988-01-28
EP0160256A3 (en)	1987-07-29
CA1259073A (fr)	1989-09-05
ATE37545T1 (de)	1988-10-15
US4762853A (en)	1988-08-09
US4668691A (en)	1987-05-26
ES8702396A1 (es)	1986-12-16
ES551452A0 (es)	1986-12-16
KR850008673A (ko)	1985-12-21
HUT38096A (en)	1986-04-28
ES8701746A1 (es)	1986-12-01
ES551451A0 (es)	1986-12-01
DE3565263D1 (en)	1988-11-03
DE3416293A1 (de)	1985-11-07
EP0160256B1 (fr)	1988-09-28
EP0160256A2 (fr)	1985-11-06
ES542564A0 (es)	1986-05-16

Similar Documents

Publication	Publication Date	Title
IE821827L (en)	1983-01-30	Dihydropyridines with a positive inotropic action
DK275488A (da)	1988-11-22	Indolonderivater
RU98119956A (ru)	2000-09-20	Раствор для хранения роговицы, включающий гиалуроновую кислоту, способ хранения ткани роговицы и применение раствора для хранения тканей роговицы
TR199701121T1 (xx)	1998-03-21	Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
EP0344997A3 (fr)	1990-09-26	Utilisation de l'acide phytique ou d'un de ses sels comme activateur des cellules hypoxiques et comme améliorateur circulatoire
FR2679135B1 (fr)	1995-05-19	Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.
FR2432520A1 (fr)	1980-02-29	Nouvelles imidazoquinoxalines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
IL68612A (en)	1987-10-30	2-aryltetraazaindenes,their preparation and pharmaceutical compositions containing them
ES8702396A1 (es)	1986-12-16	Procedimiento para la obtencion de furanonas.
AU586187B2 (en)	1989-07-06	7-``2-(dialkylamino)ethyl``-4-hydroxy-1, 3-benzimidazol-2- ones
IT1151953B (it)	1986-12-24	Composizione farmaceutica per la cura di affezioni della cavita' orale
ES556552A0 (es)	1987-12-01	Un procedimiento para preparar un derivado de 1,5-benzotiazepina
NO840526L (no)	1984-08-16	Derivater av n-iminopyridiniumbetainer, fremgangsmaate til deres fremstilling og deres anvendelse i medikamenter
EP0157324A3 (en)	1987-06-16	Tetrahydrothienopyridines, process for their preparation and their pharmaceutical application
FR2597097B1 (fr)	1988-12-02	Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
DK157875C (da)	1990-08-20	Vandoploeselige rifampicinderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
TR200102087T2 (tr)	2001-12-21	Yeni morfolinbenzamid tuzları
RU94018525A (ru)	1996-03-20	Замещенные 2-гидрокси-3[1-(1н-имидазол-4-ил)алкил]-бензолкарбоксимидамиды, способы их получения и фармацевтическая композиция на их основе
DK0541726T3 (da)	2000-08-21	Vækstfaktorsammensætninger, fremstilling og anvendelse
GR861646B (en)	1986-10-30	4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidino-5-carbonic acid -(n-triphthoro - methyl-phenyl)-amides for antithrombotic protection and treatment use and preparation of antithrombotically active medicines
FR2512673B1 (fr)	1986-04-11	Sels physiologiquement acceptables de l'acide g-butyrolactone-g-carbonyl-histidyl-prolinamide, ayant des proprietes anti-epileptiques
IL81197A0 (en)	1987-08-31	Methionine-substituted 1,4-dihydropyridines,their preparation and medicaments containing them
IL67168A0 (en)	1983-03-31	1-furyl-3,4-dihydroisoquinolines,their preparation and pharmaceutical compositions containing them
ES2121071T3 (es)	1998-11-16	Compuestos de oxazolidina y su empleo como medicamentos.
SE8603517L (sv)	1987-02-22	Heterocykliska foreningar och deras framstellning och farmaceutiska formuleringar

Legal Events

Date	Code	Title	Description
1997-03-16	FD1A	Patent lapsed	Effective date: 19970203